Suppr超能文献

相似文献

1
Regulated virulence controls the ability of a pathogen to compete with the gut microbiota.
Science. 2012 Jun 8;336(6086):1325-9. doi: 10.1126/science.1222195. Epub 2012 May 10.
2
Microbiology. Virulence or competition?
Science. 2012 Jun 8;336(6086):1238-9. doi: 10.1126/science.1223303. Epub 2012 May 10.
4
Citrobacter amalonaticus Inhibits the Growth of Citrobacter rodentium in the Gut Lumen.
mBio. 2021 Oct 26;12(5):e0241021. doi: 10.1128/mBio.02410-21. Epub 2021 Oct 5.
5
Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal Elimination.
Cell Host Microbe. 2015 May 13;17(5):617-27. doi: 10.1016/j.chom.2015.04.001. Epub 2015 Apr 30.
7
Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut.
mBio. 2016 Jun 7;7(3):e00826-16. doi: 10.1128/mBio.00826-16.
9
Indole Signaling at the Host-Microbiota-Pathogen Interface.
mBio. 2019 Jun 4;10(3):e01031-19. doi: 10.1128/mBio.01031-19.
10
Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells.
Mucosal Immunol. 2017 May;10(3):602-612. doi: 10.1038/mi.2016.77. Epub 2016 Sep 14.

引用本文的文献

1
Convergent evolution of distinct D-ribulose utilisation pathways in attaching and effacing pathogens.
Nat Commun. 2025 Jul 29;16(1):6976. doi: 10.1038/s41467-025-62476-5.
2
Non-antibiotics disrupt colonization resistance against enteropathogens.
Nature. 2025 Jul 16. doi: 10.1038/s41586-025-09217-2.
3
Gut microbiota dysbiosis in inflammatory bowel disease: interaction with intestinal barriers and microbiota-targeted treatment options.
Front Cell Infect Microbiol. 2025 Jun 27;15:1608025. doi: 10.3389/fcimb.2025.1608025. eCollection 2025.
4
The accessory type III secretion system effectors collectively shape intestinal inflammatory infection outcomes.
Gut Microbes. 2025 Dec;17(1):2526134. doi: 10.1080/19490976.2025.2526134. Epub 2025 Jul 2.
5
The Role of -Sorbose Metabolism in Enhancing Fitness and Virulence in Under Acidic Conditions.
Infect Drug Resist. 2025 Jun 20;18:3071-3086. doi: 10.2147/IDR.S526664. eCollection 2025.
7
The gut microbiome: an emerging epicenter of antimicrobial resistance?
Front Microbiol. 2025 May 20;16:1593065. doi: 10.3389/fmicb.2025.1593065. eCollection 2025.
8
Defining enteric bacterial pathogenesis using organoids: uses EspC, an atypical mucinolytic protease, to penetrate mouse colonic mucus.
Gut Microbes. 2025 Dec;17(1):2494717. doi: 10.1080/19490976.2025.2494717. Epub 2025 May 5.
9
Harnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria.
Front Immunol. 2025 Mar 17;16:1563450. doi: 10.3389/fimmu.2025.1563450. eCollection 2025.
10
Inducible transposon mutagenesis identifies bacterial fitness determinants during infection in mice.
Nat Microbiol. 2025 May;10(5):1171-1183. doi: 10.1038/s41564-025-01975-z. Epub 2025 Mar 27.

本文引用的文献

3
A human gut microbial gene catalogue established by metagenomic sequencing.
Nature. 2010 Mar 4;464(7285):59-65. doi: 10.1038/nature08821.
4
Induction of intestinal Th17 cells by segmented filamentous bacteria.
Cell. 2009 Oct 30;139(3):485-98. doi: 10.1016/j.cell.2009.09.033.
5
6
Utility of the Citrobacter rodentium infection model in laboratory mice.
Curr Opin Gastroenterol. 2008 Jan;24(1):32-7. doi: 10.1097/MOG.0b013e3282f2b0fb.
8
Citrobacter rodentium of mice and man.
Cell Microbiol. 2005 Dec;7(12):1697-706. doi: 10.1111/j.1462-5822.2005.00625.x.
9
10
Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies.
Infect Immun. 2004 Jun;72(6):3315-24. doi: 10.1128/IAI.72.6.3315-3324.2004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验